Search
Powered by Google
Member Login
Bristol-Myers Squibb Company (NYSE: BMY) and the Gladstone Institutes today announced the formation of a discovery-based research collaboration to identify and validate novel targets in Alzheimer’s disease.
Business Wire
Today Is: Saturday, May 18, 2013
May Events
Full calendar | Add to Outlook/iCal